A: Jörg Müller
Chefarzt: Klinik für Neurologie mit Stroke Unit, Vivantes Klinikum Spandau
Ärztlicher Direktor: Direktorium im Vivantes Klinikum Spandau, Vivantes Klinikum Spandau

Prof. Dr. Jörg Müller

Schwerpunkte
  • Parkinson und neurologische Bewegungsstörungen
  • Schlaganfall
  • Neuromuskuläre Erkrankungen
  • Tiefe Gehirnstimulation
  • Botulinum Toxin Therapie

Vita

seit 2018
Ärztlicher Direktor, Vivantes Klinkum Spandau, Berlin

2014 - 2017
Stellvertetender ärztlicher Direktor, Vivantes Klinkum Spandau, Berlin

seit 2008
Chefarzt, Klinik für Neurologie, Vivantes Klinikum Spandau, Berlin

2003
Habilitation an der Medizinischen Fakultät der Leopold-Franzens Universität, Innsbruck

2003 - 2008
Oberarzt der Universitätsklinik für Neurologie, Innsbruck

1997 - 2008
Klinischer und wissenschaftlicher Mitarbeiter der Uni-Klinik für Neurologie, Medizinische Universität Innsbruck

seit 1995
Wissenschaftliche und Lehrtätigkeit mit Schwerpunkten Parkinson, Tremorerkrankungen, Dystonie, Botulinum-Toxin-Therapie, Bewegungsanalyse, Neurophysiologie, Genetik.

1995 - 1997
Klinischer und wissenschaftlicher Mitarbeiter , Uni-Klinik für Neurochirurgie, Charité, Berlin
 

Publikationen

  • Mueller J, Langbein T, Mishra A, Baum RP. Safety of high-dose Botulinum Toxin injections for parotid and submandibular gland radioprotection. Toxins 2022, 14, x. DOI:org/10.3990.
  • Koy A, Kühn AA, Huebl J, Schneider G-H, … Mueller J, et al. Quality of life after bilateral pallidal stimulation of pediatric patients with dyskinetic cerebral palsy (STIM-CP). Movement Disorders 2021 Dec 29. Doi: 10.1002/mds.28898.
  • Gandor F, Kübler D, Ebersbach G, Kühn AA, Mueller J, Klostermann F, Müller T. TEMP- Therapy Escalation in M. Parkinson – A German Regional Multicenter Survey. Austin J Clin Neurol 2021:8(3): 1-4.
  • Schwarz C, Mueller, J, Wissel J, Kivi A. Dysphagia and spastic movement disorders after Stroke. Der Nervenarzt 2021:92(4): 166-167.
  • Huang K, Baur ADJ, Mueller J, et al. PSMA-Positivität der Speicheldrüsen in der Ga-68-PSMA-PET: Spielt Nüchternheit eine Rolle? Nuklearmedizin 2020:59(02): 103
  • Jost WH, MuellerJ. Drugs in the Treatment of Dystonia, Multisystem Atrophy, and Non-Parkinson Tremor. NeuroPsychopharmacotherapy 2020: In: Riederer P, Laux G, Mulsant B, Le W, Nagatsu T (eds). Springer, Cham. https://doi.org/10.1007/978-3-319-56015-1_219-1
  • Steigerwald F, Kirsch AD, Kühn AA, Kupsch A, Mueller J, Eisner W, Deuschl G, Falk D, Schnitzler A, Skogseid IM, Vollmer-Haase J, Ip CW, Tronnier V, Vesper J, Volkmann J. Evaluation of a programming algorhithm for deep brain stimulation in dstonia used in a double-blind, sham-controlled multicenter study. Neurological Research and Practice 2019: https://doi.org/10.1186/s42466-019-0032-2
  • Gruber D, Südmeyer, M, Deuschl G, Falk D, Krauss K, Mueller J, et al. Neurostimulation in tardive dystonia/dyskinesia: A delayed start, sham stimulation-controlled randomized trial. Brain Stimulation 2018:11(6): 1368-1377.
  • Hopmann D, Kivi A, Riesch E, Alishammat A, Al-Ajmi A, Wissel J, Mueller J. P43 A novel deletion in two exoms of the SH3TC2 gene with mutation in the DPYD gene in Charcot-Marie-Tooth disease type 4c. Clinical Neurophysiology 2017:128(10):e351-e352.
  • Pauls AM, Krauss JK, Kaempfer CE, Kühn A, Schrader C, Südmeyer M, Allert N, Benecke R, Blahak C, Boller JK, Fink GR, Fogel W, Liebig T, Majdoub F, Mahlknecht P, Kessler J, Mueller J, Voges J, Timmermann L.  Causes of failure of pallidal deep brain stimulation in cases with pre-operative diagnosis of isolated dystonia. Parkinsonism & Related Disorders 2017;43: 38-48.
  • Koy A, Kühn AA, van Riesen A, Huebl J, Korinthenberg R, Coenen VA, Krauss JK, Wloch A, Lorenz D, Haussler M, Schnitzler A, Vesper J, Alesch F, Lehmacher W, Mueller J, et al.. Effect of Deep Brain Stimulation of the Globus Pallidus Internus on Quality of Life in Young Patients with Dyskinetic Cerebral Palsy (STIM-CP): A Prospective Single-Arm Multicenter Trial with a Double-Blind Cross-Over at 12-months Follow-up. Journal of Clinical Trials 2017: DOI: 10.4172/2167-0870.1000317
  • Zech M, Boesch S, Joachim A, Weber S, Meindl T, Schormair B, Wieland T, Lunetta C, Sansone V, Messner M, Mueller J, et al. Clinical exome sequencing in early-onset generalized dystonia and large-scale resequencing follow-up. Mov Disord 2017:32(4): 549-559.
  • Zech M, Joachim A, Boesch S, Weber S, Meindl T, Peters A, Gieger C, Mueller J, et al. Systematic TOR1A non-c.907_909delGAG variant analysis in isolated dystonia and controls. Parkinsonism & Related Disorders 2016;31: 119-123.
  • Neumann W-J, Staub F, Horn A, Schanda J, Mueller J, Schneider G-H, Brown P, Kühn AA. Deep brain recordings using an implanted pulse generator in Parkinson`s disease. Neuromodulation 2016:19(1): 20-24
  • Dinkelbach L, Mueller J, Poewe W, et al. Cognitive outcome of pallidal deep brain stimulation for primary cervical dystonia: One year follow up results of a prospective multicenter trial. Parkinsonism & Related Disorders 2015;21(8):976-980.
  • Zech M, Boesch S, Joachim A, Graf S, Lichtner P, Peters A, Gieger C, Mueller J, et al. Large-scale TUBB4A mutational screening in isolated dystonia and controls. Parkinsonism & Related Disorders 2015;21(10):1278-1281
  • Zech M, Boesch S, Sycha T, Mueller J, et al. TOR1A, THAP1, and GNAL mutational screening in Austrian patients with primary isolated dystonia. Mov Disord 2015:30(13):1853-1854.
  • Volkmann J, Müller J, Deuschl G, et al. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol. 2014;13(9):875-884.
  • Hopmann D, Kivi A, Stenzel W, Ehret R, Mueller J. Late Onset Myopathy and Hyperkinetic Movement Disorder. Clinical Neurophysiology 2014: DOI: 10.1016/S1388-2457(14)50684-0.
  • Wissel J, Mueller J. Behandlung der Spastizität mit Botulinumtoxin-Typ-A-Injektionen. Nervenheilkunde 2013:32(12):933-938.
  • Spielberger S, Hotter A, Wolf E, Eisner W, Müller J, Poewe W. Deep brain stimulation in Huntington`s disease: A 4-year follow-up case report. Mov Disord 2012;27(6):806-807
  • Volkmann J, Wolters A, Kupsch A, Mueller J, Kühn AA, Schneider GH, et al. Pallidal deep brain stimulation in patients with primary generalized or segmental dystonia: 5-year follow-up of a randomised trial. Lancet Neurol. 2012;11(12):1029-38.
  • Hefter H, Kupsch A, Müngersdorf M, Paus S, Stenner A, Jost W, Müller J et al. (Dysport Cervical Dystonia Study Group). A botulinum toxin A treatment algorithm for de novo management of torticollis and laterocollis. BMJ Open 2011;1(2):e000196
  • J. Wissel, L. Schelosky, J. Scott, W. Christe, J. Faiss, J. Mueller. Early development of spasticity following stroke: a prospective, observational trial. J Neurol 2010,257:1067-1072
  • J. Mueller. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial. Mov Disord 2009;24(7):1098-99
  • F. Asmus, R. v.Coelln, A. Boertlein, T. Gasser, J. Mueller. Reverse sensory geste in cervical dystonia. Mov Disord 2009,24(2):297-300
  • J. Mueller, I.M. Skogseid, R. Benecke, A. Kupsch, T. Trottenberg, W. Poewe, G.H. Schneider, W. Eisner, A. Wolters, J.U. Müller, G. Deuschl, M.O. Pinsker, G.K. Roeste, J. Vollmer-Haase, A. Bentrup, M. Krause, V. Tronnier, A. Schnitzler, J. Voges, G. Nikkhah, J. Vesper, M. Naumann, J. Volkmann. Pallidal deep brain stimulation improves Quality of Life in segmental and generalized dystonia: Results from a prospective, randomized sham-controlled trial. Mov Disord 2008;23(1):131-134
  • M. Köllensperger, F. Geser, K. Seppi, M. Stampfer-Kountchev, M. Sawires, C. Scherfler, S. Boesch, J. Mueller, … W. Poewe, G.K. Wenning on behalf of the European MSA Study Group. Red flags for Multiple System Atrophy. Mov Disord 2008;23(8):1093-1099
  • M. Kofler, J. Mueller, M. Rinnerthaler, J. Valls-Solé. Laterality of auditory startle responses in humans. Clin Neurophysiol 2008;119:309-324
  • Mueller J, Skogseid IM, Benecke R, et al. Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: Results from a prospective, randomized sham-controled trial. Mov Disord 2008:23(1): 131-134.
  • Mueller J, Poewe W. Writer`s cramp, limb dystonia and other task-specific dystonias. Clinical Diagnosis and Management of Dystonia 2007: DOI: 10.3109/9780203640487-11
  • H. Stockner, M. Sojer, K. Seppi, J. Mueller, G.K. Wenning, C. Schmidauer, W. Poewe. Midbrain sonography in patients with essential tremor. Mov Disord 2007;22(3):414-417
  • S. Hering, G.K. Wenning, K. Seppi, W. Poewe, J. Mueller. An open trial of levetiracetam for segmental and generalized dystonia. Mov Disord 2007;22(11):1649-1651
  • J. Mueller, M. Rinnerthaler, W. Poewe, M. Kofler. Auditory startle reaction in primary blepharospasm. Mov Disord 2007,22(2):268-272
  • K. Egger, J. Mueller, M. Schocke, C. Brenneis, M. Rinnerthaler, K. Seppi, T. Trieb, G.K. Wenning, M. Hallett, W. Poewe. Voxel based morphometry reveals specific gray matter changes in primary dystonia. Mov Disord 2007;22(11):1538-1542
  • W. Loescher, M. Stampfer, M. Sawires, K. Seppi, J. Mueller, C. Szubski, K. Hirnsperger, C. Brenneis, W. Poewe, G.K. Wenning. Abnormal responses to repetitive transcranial magnetic stimulation in multiple system atrophy. Mov Disord 2007;22(2):174-178
  • M. Köllensperger, K. Seppi, C. Liener, S. Boesch, D. Heute, K.J. Mair, J. Mueller, M. Sawires, C. Scherfler, M.F. Schocke, E. Donnemiller, I. Virgolini, G.K. Wenning, W. Poewe. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy. Mov Disord 2007;22(12):1771-1776
  • Wissel J, auf dem Brinke M, Huber M, Herrmann C, Winterholler M, Hecht MJ, Lobsien E, Stolze H, Treig A, Mueller J. Praxis der fokalen Therapie der Spastik mit Botulinumtoxin A in sieben spezialisierten deutschen Zentren. Klinische Neurophysiologie 2007:38(04).
  • Frauscher B, Gschliesser V, Brandauer E, Peralta CM, Mueller J, et al. Video analysis of motor events in REM sleep behavior disorder. Mov Disord 2007:22(10): 1464-1470.
  • Wissel, J, Mueller J, Baldauf A, Ung SC, Ndayisaba J-P, Stoeckl B, Frischhut B, Haberfellner H, Poewe W. Gait analysis to assess the effects of botulinum toxin type A treatment in cerebral palsy: An open-label study in 10 children with equinus gait pattern. Eur J of Neurology 2007:6(S4): s63-s67.
  • Boesch S, Mueller J, Wenning GK, Poewe W. Cervical dystonia in spinocerebellar ataxia type 2: Clinical and polymyographic findings. JNNP 2007:78(5): 520-522.
  • Hering S, Mueller J, Rinnerthaler M, Poewe W, Kofler M. Audiogene Schreckreaktion bei primärem Blepharospasmus. Klinische Neurophysiologie 2007:38(01).
  • M. Rinnerthaler, C. Benecke, L. Bartha, T. Entner, W. Poewe, J. Mueller. Facial recognition in primary focal dystonia. Mov Disord 2006;21(1):78-82
  • M. Rinnerthaler, J. Mueller, V. Weichbold, G.K. Wenning, W. Poewe. Social stigmatization in patients with cranial and cervical dystonia. Mov Disord 2006;21(10):1636-1640
  • A. Kupsch, R. Benecke, J. Mueller, T. Trottenberg, G.H. Schneider, W. Poewe, W. Eisner, A. Wolters, J.U. Müller, G. Deuschl, M.O. Pinsker, I.M. Skogseid, G.K. Roeste, J. Vollmer-Haase, A. Bentrup, M. Krause, V. Tronnier, A. Schnitzler, J. Voges, G. Nikkhah, J. Vesper, M. Naumann, J. Volkmann. Pallidal deep brain stimulation in primary generalized or segmental dystonia. NEJM 2006;355:1978-1990.
  • C. Kamm, F. Asmus, J. Mueller, P. Mayer, M. Sharma, U.J. Muller, S. Beckert, R. Ehling, T.Illig, H.E. Wichmann, W. Poewe, J.C. Mueller, T. Gasser. Strong genetic evidence for association of TOR1A/TOR1B with idiopathic dystonia. Neurology 2006;67;1857-1859
  • J. Wissel, T. Haydn, J. Mueller, L.D. Schelosky, C. Brenneis, T. Berger, W. Poewe. Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain. J Neurol 2006;253:213-219
  • S. Mechtcheriakov, I.W. Graziadei, A. Kugener, I. Schuster, J. Mueller, H. Hinterhuber, W. Vogel, J. Marksteiner. Motor dysfunction in patients with liver cirrhosis: impairment of handwriting. J Neurol 2006;253(3):349-356
  • K. Seppi, C. Peralta, A. Diem, Z. Puschban, J. Mueller, W. Poewe, G.K. Wenning. Placebo-controlled trial of riluzole in multiple system atrophy. Eur J Neurol 2006;13(10):1146-1148.
  • T. Trottenberg, J. Volkmann, G. Deuschl, A.A. Kuhn, G.H. Schneider, J. Mueller, F. Alesch, A. Kupsch. Treatment of severe tardive dystonia with pallidal deep brain stimulation. Neurology 2005;64(2):344-346
  • B. Hogl, S. Kiechl, J. Willeit, M. Saletu, B. Frauscher, K. Seppi, J. Mueller, G. Rungger, A. Gasperi, G.K. Wenning, W. Poewe. Restless legs syndrome: a community-based study of prevalence, severity, and risk-factors. Neurology 2005;64(11):1920-1924
  • K. Seppi, F. Yekhlef, A. Diem, E. Luginger, J. Mueller, F. Tison, N.P. Quinn, W. Poewe, G.K. Wenning. Progression of parkinsonism in multiple system atrophy. J Neurol 2005;252(1):91-96
  • U. Mueller, B. Frick, C. Winkler, D. Fuchs, G.K. Wenning, W. Poewe, J. Mueller. Homocysteine and serum markers of immune activation in primary dystonia. Mov Disord 2005;20(12):1663-1667
  • M. Rinnerthaler, G. Luef, J. Mueller, K. Seppi, J. Wissel, E. Trinka, G. Bauer, W. Poewe. Computerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproate. Epilepsia 2005;46(2):3210-323
  • G.K. Wenning, S. Kiechl, K. Seppi, J. Mueller, B. Hogl, M. Saletu, G. Rungger, A. Gasperi, J. Willeit, W. Poewe. Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study. Lancet Neurol 2005;4(12):815-820
  • J. Mueller, G.K. Wenning, G. Kemmler, W, Poewe. Re: Patient-based outcomes of cervical dystonia: a review of rating scales. Mov Disord 2005;20(9):1230
  • F. Paul, J. Mueller, W. Christe, T. Steinmuller, W. Poewe, J. Wissel. Postural hand tremor before and following liver transplantation and immunosuppression with cyclosporine or tacrolimus in patients without clinical signs of hepatic encephalopathy. Clin Transplant 2004;18(4):429-433
  • S.M. Boesch, E. Donnemiller, J. Mueller, K. Seppi, H. Weirich-Schwaiger, W. Poewe, G.K. Wenning. Abnormalities of dopaminergic neurotransmission in SCA2: a combined 123I-betaCIT and 123I-IBZM SPECT study. Mov Disord 2004;19(11):1320-1325
  • B. Voller, E. Moraru, E. Auff, M. Benesch, W. Poewe, J. Wissel, J. Mueller, T. Entner, H. Bigalke, P. Schnider. Ninhydrin sweat test: a simple method for detecting antibodies neutralizing botulinum toxin type A. Mov Disord 2004;19(8):943-947
  • J. Mueller, J. Wissel, G. Kemmler, B. Voller, T. Bodner, A. Schneider, G.K. Wenning, W. Poewe. Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry 2004;75(5):749-753
  • M. Kofler, J. Mueller, K. Seppi, G.K. Wenning. Exaggerated auditory startle responses in multiple system atrophy. Clin Neurophysiol 2003;114(3):541-547
  • J. Wissel, J. Mueller, W. Poewe. EMG for identification of dystonic, tremulous and spastic muscles and techniques for guidance of injections. In: P. Moore, M. Naumann (eds.). Handbook of Botulinum Toxin Treatment, 2nd ed..Blackwell Science Ltd. 2003:pp 76-98
  • J. Mueller, M. Kofler, G.K. Wenning, K. Seppi, J. Valls-Solé, W. Poewe. The auditory startle response in cervical dystonia. Mov Disord 2003,18:1522-1526
  • C. Brenneis, K. Seppi, M.F. Schocke, J. Mueller, E. Luginger, S. Boesch, W.N. Loscher, C. Buchel, W. Poewe, G.K. Wenning. Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 2003;18(10):1132-1138
  • K. Seppi, M.F. Schocke, R. Esterhammer, C. Kremser, C. Brenneis, J. Mueller, S. Boesch, W. Jaschke, W. Poewe, G.K. Wenning. Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 2003;60(6):922-927
  • J. Mueller, S. Kiechl, G.K. Wenning, K. Seppi, J. Willeit, A. Gasperi, J. Wissel, T. Gasser, W. Poewe. The prevalence of primary dystonia in the general community. Neurology 2002;59:941-943
  • O. Bandmann, F. Asmus, D. Sibbing, M. Grundmann, S. Schwab, J. Mueller, D. Wildenauer, W. Poewe, T. Gasser, W.H. Oertel. Copper genes are not implicated in the pathogenesis of focal dystonia. Neurology 2002;10:782-783
  • J. Mueller, I. Litvan, K. Seppi, N. Stefanova, W. Poewe G.K. Wenning. Freezing of gait in atypical parkinsonian disorders: a clinicopathologic study. Mov Disord 2002;17:1041-1045
  • J. Mueller, G.Kemmler, J. Wissel, A. Schneider, B. Voller, J. Grossmann, J. Diez, N. Homann, G.K. Wenning, P. Schnider, W. Poewe and the Austrian Botulinum Toxin and Dystonia Study Group. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol 2002;249:842-846
  • J. Mueller, G.K. Wenning, J. Wissel, K. Seppi, W. Poewe. Botulinum Toxin treatment in atypical parkisonian disorders associated with disabling focal dystonia. J Neurol 2002;249:300-304
  • J. Mueller, G.K. Wenning, J. Wissel, A. Baldauf, K. Seppi, C. Brenneis, W. Poewe. Riluzole therapy in cervical dystonia. Mov Disord 2002;17(1):198-200
  • G. Ebersbach, M. Sojer, J. Mueller, G. Ransmayr, G.Wenning, W. Poewe. Gleichgewichts-störungen bei idiopathischer Parkinsonerkrankung. Nervenarzt 2002;73:162-165
  • J. Mueller, J. Wissel, G. Ebersbach, W. Poewe. Dynamic balance function in phasic cervical dystonia following Botulinum toxin therapy. Mov Disord 2001;16(5):934-937
  • J. Mueller, J. Wissel, F. Masuhr, G. Ebersbach, G.K. Wenning, W. Poewe. Clinical characteristics of the geste antagoniste in cervical dystonia. J Neurol 2001;248:478-482
  • J. Mueller, G.K. Wenning, J. Wissel, W. Poewe. Intrafamilial heterogeneity of facial hyperkinesias: a chance association of tics, cranial dystonia, and Huntington`s Disease? Mov Disord 2001;16(2):370-372
  • J. Mueller, G.K. Wenning, M. Verny, A. McKee, K Ray Chaudhuri, K Jellinger, W. Poewe, I. Litvan. Progression of dysarthria and dysphagia in postmortem confirmed parkinsonian disorders. Arch Neurol 2001;58:259-264
  • M. Kofler, J. Mueller, G.K. Wenning, L. Reggiani, P. Hollosi, S. Bösch, G. Ransmayr, J. Valls-Solé, W. Poewe. The auditory startle reaction in parkinsonian disorders. Mov Disord 2001;16(1):62-71
  • M. Kofler, J. Mueller, L. Reggiani, J. Valls-Solé. Influence of age on auditory startle responses in humans. Neuroscience Letters 2001;307:65-68
  • M. Kofler, J. Mueller, L. Reggiani, J. Valls-Solé. Influence of gender on auditory startle responses. Brain Research 2001;921:206-210
  • J. Wissel, P. Kanovsky, E. Ruzicka, M. Bares, H. Hortova, H. Streitova, R. Jech, J. Roth, C. Brenneis, J. Mueller, P. Schnider, E. Auff, A. Richardson, W. Poewe. Efficacy and safety of a standardized 500 unit dose of Dysport in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study. J Neurol 2001;248:1073-1078
  • K. Seppi, Z. Puschban, N. Stefanova, C. Scherfler, J. Mueller, W. Poewe, G.K. Wenning. Overstimulation of the 1B-adrenergic receptor causes a „seizure plus“ syndrome. Nature Med 2001;7(2):132
  • K. Seppi, J. Mueller, T. Bodner, E. Brandauer, T. Benke, H. Weirich-Schwaiger, W. Poewe, G.K. Wenning. Riluzole in Huntington`s disease (HD): an open label study with one year follow up. J Neurol 2001;248:866-869
  • M. Sojer, J. Wissel, J. Mueller, W. Poewe. Treatment of focal dystonia with botulinum toxin A. Wien Klin Wochenschrift 2001;113(Suppl.4):6-10
  • M. Kofler, J. Wissel, J. Mueller, C. Brenneis, W. Poewe. Influence of intrathecal baclofen on silent periods in dystonia. Muscle Nerve 2000;23(7):1145-1146
  • F. Masuhr, J. Wissel, J. Mueller, U. Scholz, W. Poewe. Quantification of sensory trick impact on tremor amplitude and frequency in 60 patients with head tremor. Mov Disord 2000;15:960-964
  • C. Kamm, M. Naumann, J. Mueller, N. Mai, L. Riedel, J. Wissel, T. Gasser. The DYT1 GAG depletion is infrequent in sporadic and familial writer`s cramp. Mov Disord 2000;15:1238-1241
  • G. Ebersbach, M. Sojer, J. Mueller, M. Heijmenberg, W. Poewe. Socio-cultural differences in gait. Mov Disord 2000;15:1145-1147
  • M. Kofler, J. Wissel, J. Mueller, C. Brenneis. Influence of intrathecal baclofen on silent periods in dystonia. Muscle Nerve 2000;23(7): 1145-1146
  • A.M. Bakheit, A.F. Thilmann, A.B. Ward, W. Poewe, J. Wissel, J. Mueller, R. Benecke, C. Collin, F. Muller, C.D. Ward, C. Neumann. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000;31(10):2402-2406
  • M. Kofler, J. Mueller, L. Reggiani, G.K. Wenning. Somatosensory evoked potentials in progressive supranuclear palsy. J Neurol Sci 2000;179:85-91
  • J. Wissel, J. Mueller, J Dressnandt, F. Heinen, M. Naumann, H. Topka, W. Poewe. Management of spasticity associated pain with Botulinum Toxin A. J Pain Symptom Manage 2000;20(1):44-49
  • J. Mueller, G.K. Wenning, K. Jellinger, A. McKee, W. Poewe, I. Litvan. Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study. Neurology 2000;55(6):888-891
  • G. Ebersbach, M. Stoeck, J. Mueller, J. Wissel, W. Poewe. Dopa-responsiver Haltetremor bei idiopathischer Parkinson-Erkrankung. Akt Neurol 2000;27:327-331
  • J. Wissel, J. Mueller, G. Ebersbach, W. Poewe. Trick maneuvers in Cervical Dystonia: Investigation of movement- and touch-related changes in polymyographic activity. Mov Disord 1999;14(6):994-999
  • G. Ebersbach, M. Sojer, J. Wissel, J. Mueller, F. Valldeoriola, W. Poewe. Comparative analysis of gait in Parkinson`s Disease, cerebellar ataxia and subcortical arteriosclerotic enzephalopathy. Brain 1999;122:1349-1355
  • J. Wissel, A. Schenkel, F.Heinen, G. Ebersbach, B. Doll, J. Mueller, W. Poewe. Botulinum Toxin Type A in the management of spastic gait disorders in children with Cerebral Palsy: A randomized, double blind study of “high-dose“ versus “low-dose“ treatment. Neuropediatrics 1999;30:1-5
  • J. Mueller, G. Ebersbach, J. Wissel, C. Brenneis, L. Badry, W. Poewe. Disturbances of dynamic balance in phasic cervical dystonia. J Neurol Neurosurg Psychiatry 1999;67(6):807-810
  • G. Ebersbach, M. Stöck, J. Mueller, G. Wenning, J. Wissel, W. Poewe. Worsening of motor performance in patients with Parkinson`s disease following transdermal nicotine administration. Mov Disord 1999;14(6):1011-1013
  • P. Birner, P. Schnider, J. Mueller, J. Wissel, I. Fuchs, E. Auff. Torticollis spasmodicus, Blepharospasmus und hemifacialer Spasmus. Subjektive Bewertung der Therapie durch Patienten. Nervenarzt 1999;70:903-908.
  • J. Wissel, J. Mueller, F. Heinen, V. Mall, W. Poewe. Sicherheit und Verträglichkeit einer einmaligen Botulinum Toxin Behandlung bei 204 Patienten mit Spastizität und lokalen assoziierten Störungen. Wien Klin Wochenschr 1999;111/20:837-842.
  • J. Wissel, J. Mueller, A. Baldauf, S.C. Ung, J.P. Ndayisaba, B. Stöckl, B. Frischhut, H. Haberfellner, W. Poewe. Gait analysis to assess the effects of botulinum toxin type A treatment in cerebral palsy: an open-label study in 10 children with equinus gait pattern. Europ J of Neurol 1999;6 (suppl 4):S63-S67
  • J. Mueller, C. Bührer, K. Kiening, T. Kerner, H. Gerlach, M. Obladen, A. Unterberg, W. Lanksch. Decreased soluble adhesion molecule L-Selectin Plasma Concentrations after Major Trauma. J Trauma 1998;45(4):705-708.

Fachgesellschaften

  • International Movement Disorders Society
  • Deutsche Gesellschaft für Neurologie
  • AG Tiefe Hirnstimulation der DGN
  • AK Botulinum Toxin der Deutschen Gesellschaft für Neurologie
  • Berliner Gesellschaft für Psychiatrie und Neurologie
  • Deutsche Gesellschaft für klinische Neurophysiologie
  • Deutsche Gesellschaft für Neurorehabilitation
  • Deutsche Parkinsongesellschaft
  • Deutsche Schlaganfall-Gesellschaft
  • Österreichische Dystonie- und Botulinum Toxin Arbeitsgruppe
  • Österreichische Gesellschaft für klinische Neurophysiologie
  • Österreichische Parkinsongesellschaft